Skip to main navigation Skip to search Skip to main content

Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C

  • Basil Rigas
  • , Izhar Hasan
  • , Raja Rehman
  • , Peter Donahue
  • , Knut M. Wittkowski
  • , Edward Lebovics
  • New York Medical College
  • Dia-Sorin Inc.
  • Rockefeller University

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

The newly discovered SEN D and SEN H viruses are transmitted parenterally and can cause post-transfusion hepatitis. We assessed whether coinfection of patients with chronic hepatitis C and SEN D or SEN H correlates with the outcome of treatment with interferon and ribavirin. Of 31 patients with hepatitis C studied, six were positive for SEN D and seven for SEN H (one was positive for both). All of those positive for SEN D and five of those positive for SEN H failed to respond to therapy. Overall response (RNA titre and alanine aminotransferase concentration after treatment) was lower in SEN-infected patients than uninfected patients (p=0.025). We conclude that coinfection with SEN viruses is frequent in chronic hepatitis C patients and might adversely affect the outcome of treatment with interferon and ribavirin.

Original languageEnglish
Pages (from-to)1961-1962
Number of pages2
JournalThe Lancet
Volume358
Issue number9297
DOIs
StatePublished - Dec 8 2001

Fingerprint

Dive into the research topics of 'Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C'. Together they form a unique fingerprint.

Cite this